drug summary · 3 NDC codes
ABRILADA
adalimumab-afzb
HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status BLA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.
dataset id 66854NDC codes 3application BLA761118RxCUI —
Facts
Field definitions, types, and provenance rules are in the data dictionary.
| generic name | adalimumab-afzb |
|---|---|
| active ingredients | not reported |
| dosage form | KIT |
| route | not reported |
| strength | not reported |
| marketing status | BLA |
| DEA schedule | not reported |
| application number | BLA761118 |
| ATC code | not reported |
| RxCUI | not reported |
| manufacturer | Pfizer Laboratories Div Pfizer Inc |
| product type | HUMAN PRESCRIPTION DRUG |
| pharmacologic class | not reported |
NDC codes
3 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.
| NDC | Package description |
|---|---|
| 00025032501 | — |
| 00025032502 | — |
| 0025-0325 | — |
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access to the full catalogue; credited toward the licence.